The Panbio™ COVID-19 Ag Rapid Test Device (Nasopharyngeal) is a high-performance rapid test for patients suspected of current COVID-19 infection.
The Panbio™ enables immediate treatment or isolation measures to minimize transmission.
- Patient-friendly nasal or nasopharyngeal sample collection types.
- Accessible, large-scale testing helps contain the virus spread.
- Fast identification of potentially contagious individuals
- Test results in 15 minutes
- Deploy at large scale at point-of-care
- Can be used in a wide variety of non-laboratory settings
- No special/additional instruments required
- Self-contained tube with “break off” swab minimizes staff exposure
- Extraction tube is fully enclosed for disposal
The Panbio™ COVID-19 Ag Rapid Test Device (Nasopharyngeal) is manufactured by Abbott and is approved for use by the Therapeutic Goods Administration (TGA) .
Buy Panbio™ COVID-19 Ag Rapid Test Device (Nasopharyngeal) for Your WorkPlace
If your company or organisation is interested in rapid testing solutions, contact us today for help procuring the Panbio™ COVID-19 Ag Rapid Test Device (Nasopharyngeal) or other rapid tests authorised by the Therapeutic Goods Administration (TGA) .
If you’re interested in rapid testing solutions, contact us today for a quote. You can also place an order for the Abbott Panbio™ COVID-19 Rapid Antigen Test Device (Nasopharyngeal) or other rapid tests approved by the TGA.
Our team at Rapid Tests Australia can also assist with implementing a rapid testing program to protect your workplace from the risks of COVID-19.
